Combined assessment of midbrain hyperechogenicity, hyposmia and motor asymmetry improves diagnostic accuracy in early Parkinson's disease

Expert Review of Neurotherapeutics

Volumn 12, Issue 8, 2012, Pages 911-914

  Poewe, Werner ^a   Mahlknecht, Philipp ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

early diagnosis; hyposmia; motor asymmetry; Parkinson's disease; substatia nigra hyperechogenicity

Indexed keywords

BRAIN ASYMMETRY; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE COURSE; HUMAN; HYPOSMIA; MESENCEPHALON; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PARKINSONISM; REVIEW; SENSITIVITY AND SPECIFICITY; TREMOR;

EID: 84866696660     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.12.75     Document Type: Review

References (28)

1. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinsons disease. J. Neurol. Neurosurg. Psychiatr. 51(6), 745-752 (1988).
2. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinsons disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatr. 55(3), 181-184 (1992).
3. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinsons disease. Lancet Neurol. 5(1), 75-86 (2006).
4. Bain P, Brin M, Deuschl G et al. Criteria for the diagnosis of essential tremor. Neurology 54(11 Suppl. 4), S7 (2000).
5. Zijlmans JC, Daniel SE, Hughes AJ, Rvsz T, Lees AJ. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov. Disord. 19(6), 630-640 (2004).
6. Gilman S, Wenning GK, Low PA et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9), 670-676 (2008).
7. Litvan I, Bhatia KP, Burn DJ et al.; Movement Disorders Society Scientific Issues Committee. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov. Disord. 18(5), 467-486 (2003).
8. Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol. 7(11), 1044-1055 (2008).
9. Gaenslen A, Unmuth B, Godau J et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinsons disease: a prospective blinded study. Lancet Neurol. 7(5), 417-424 (2008).
10. Behnke S, Berg D, Naumann M, Becker G. Differentiation of Parkinsons disease and atypical Parkinsonian syndromes by transcranial ultrasound. J. Neurol. Neurosurg. Psychiatr. 76(3), 423-425 (2005).
11. Stockner H, Wurster I. Transcranial sonography in essential tremor. Int. Rev. Neurobiol. 90, 189-197 (2010).
12. Tsai CF, Wu RM, Huang YW, Chen LL, Yip PK, Jeng JS. Transcranial color-coded sonography helps differentiation between idiopathic Parkinsons disease and vascular parkinsonism. J. Neurol. 254(4), 501-507 (2007).
13. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38(8), 1237-1244 (1988).
14. Stern MB, Doty RL, Dotti M et al. Olfactory function in Parkinsons disease subtypes. Neurology 44(2), 266-268 (1994).
15. Braak H, Del Tredici K, Rb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinsons disease. Neurobiol. Aging 24(2), 197-211 (2003).
16. Katzenschlager R, Zijlmans J, Evans A, Watt H, Lees AJ. Olfactory function distinguishes vascular parkinsonism from Parkinsons disease. J. Neurol. Neurosurg. Psychiatr. 75(12), 1749-1752 (2004).
17. Katzenschlager R, Lees AJ. Olfaction and Parkinsons syndromes: its role in differential diagnosis. Curr. Opin. Neurol. 17(4), 417-423 (2004).
18. Djaldetti R, Ziv I, Melamed E. The mystery of motor asymmetry in Parkinsons disease. Lancet Neurol. 5(9), 796-802 (2006).
19. Lee CS, Schulzer M, Mak E, Hammerstad JP, Calne S, Calne DB. Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implications for pathogenesis. Neurology 45(3 Pt 1), 435-439 (1995).
20. Yamanouchi H, Nagura H. Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study. Stroke 28(5), 965-969 (1997).
21. Gómez-Esteban JC, Tijero B, Ciordia R et al. Factors influencing the symmetry of Parkinsons disease symptoms. Clin. Neurol. Neurosurg. 112(4), 302-305 (2010).
22. Busse K, Heilmann R, Kleinschmidt S et al. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinsons disease. J. Neurol. Neurosurg. Psychiatr. 83(4), 441-447 (2012).
23. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinsons disease. Neurology 57(8), 1497-1499 (2001).
24. Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ; Quality Standards Subcommittee of the American Academy of Neurology. Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66(7), 968-975 (2006).
25. Pahwa R, Lyons KE. Early diagnosis of Parkinsons disease: recommendations from diagnostic clinical guidelines. Am. J. Manag. Care 16(Suppl.), S94-S99 (2010).
26. Stern MB, Lang A, Poewe W. Toward a redefinition of Parkinsons disease. Mov. Disord. 27(1), 54-60 (2012).
27. Berg D, Seppi K, Behnke S et al. Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons. Arch. Neurol. 68(7), 932-937 (2011).
28. Siderowf A, Jennings D, Eberly S et al.; PARS Investigators. Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Mov. Disord. 27(3), 406-412 (2012).